Basal Cell Carcinoma (BCC) Terminated Phase 2 Trials for Sonidegib (DB09143)

Also known as: BCC - Basal Cell Carcinoma / Basal Cell Carcinomas / Basal Cell Carcinoma / Carcinoma basal cell / Basalioma / Basal cell epithelioma / Rodent ulcer / Basal cell carcinoma (morphologic abnormality) / Basal cell carcinoma of skin (disorder) / Carcinoma, Basal Cell

IndicationStatusPhase
DBCOND0040396 (Basal Cell Carcinoma (BCC))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02303041Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell CarcinomaTreatment